Effect of recombinant human erythropoietin on transfusion needs in preterm infants

Journal of Paediatrics and Child Health

Volumn 37, Issue 4, 2001, Pages 352-358

  Yeo, C L ^a   Choo, S ^a   Ho, L Y ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Recombinant human erythropoietin; Red blood cell transfusion; Very low birthweight infants

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HUMAN; INFANT; IRON THERAPY; MALE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; VERY LOW BIRTH WEIGHT;

BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; TREATMENT OUTCOME;

EID: 0034880711     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00667.x     Document Type: Article

References (29)

1. Transfusion therapy in neonates
2. Blood sampling in very low birth weight infants on different intensive care levels
3. Anemia of prematurity: Determinants of the erythropoietin response
4. Anemia of prematurity. Progress and prospects
5. Responsiveness to recombinant erythropoietin of marrow progenitors in infants with anemia of prematurity
6. Circulating erythroid progenitors in the anemia of prematurity
7. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants
8. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
9. Recombinant human erythropoietin (r-HuEPO) stimulates erythropoiesis and reduces transfusions in preterm infants
10. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birthweight less than 1500 grams
11. An interventional classification of retinopathy of prematuirty
12. Pulmonary disease following respiratory therapy for hyaline membrane disease
13. Erythropoietin responsive progenitors in anaemia of prematurity
14. Developmental hematopoiesis in normal human fetal blood
15. Efficacy and safety of recombinant human erythropoietin to prevent the anemias of prematurity. European randomised multicenter trial
16. Double blind trial of recombinant erythropoietin in preterm infants
17. Early treatment of premature infants with recombinant human erythropoietin
18. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
19. Recombinant human erythropoietin in the treatment of anemia of prematurity: A randomised, double-blind, placebo-controlled trial comparing three different doses
20. The role of erythropoietin in the anemia of prematurity
21. Effects of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
22. The effects of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double blind, placebo-controlled study
23. Recombinant human erythropoietin vs transfusion in the treatment of anemia of prematurity: A cost-benefit analysis
24. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot study
25. Effects of recombinant human erythropoietin in infants with anemia of prematurity: A pilot study
26. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity
27. Weekly intravenous administration of recombinant human erythropoietin in infants with the anemia of prematurity
28. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease